DAPIPRAZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dapiprazole, and what generic alternatives are available?
Dapiprazole is a drug marketed by Baradaina Llc and Fera Pharms and is included in two NDAs.
The generic ingredient in DAPIPRAZOLE is dapiprazole hydrochloride. There are two drug master file entries for this compound. Additional details are available on the dapiprazole hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DAPIPRAZOLE?
- What are the global sales for DAPIPRAZOLE?
- What is Average Wholesale Price for DAPIPRAZOLE?
Summary for DAPIPRAZOLE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | DAPIPRAZOLE at DailyMed |
US Patents and Regulatory Information for DAPIPRAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baradaina Llc | DAPIPRAZOLE HYDROCHLORIDE | dapiprazole hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 204902-001 | May 30, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fera Pharms | DAPIPRAZOLE HYDROCHLORIDE | dapiprazole hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019849-001 | Dec 31, 1990 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

